Continuous infusion versus intermittent bolus furosemide in ADHF: An updated meta-analysis of randomized control trials

Journal of Hospital Medicine

Volumn 7, Issue 3, 2012, Pages 270-275

  Amer, Muhammad ^a   Adomaityte, Jurga ^a   Qayyum, Rehan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ACUTE HEART FAILURE; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; DIURESIS; DOSAGE SCHEDULE COMPARISON; DRUG INTERMITTENT THERAPY; HUMAN; LENGTH OF STAY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTEMATIC REVIEW; TREATMENT DURATION; WEIGHT REDUCTION;

ACUTE DISEASE; AGED; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 84857796994     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.991     Document Type: Review

References (36)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119: e21-e181.
2. National Heart, Lung, and Blood Institute. What Is Heart Failure? Available at:. Accessed March 6, 2011.
3. Russo CA, Ho K, Elixhauser A. Hospital Stays for Circulatory Diseases, 2004. Healthcare Cost and Utilization Project Statistical Brief No. 26. Rockville, MD: Agency for Healthcare Research and Quality; February 2007. Available at:. Accessed February 22, 2010.
4. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119: 1977-2016.
5. Branck RA, Roberts CJC, Homeida M, Levine D. Determinants of response to furosemide in normal subjects. Br J Clin Pharmacol. 1977; 4: 121-127.
6. Brater DC. Diuretic therapy. N Engl J Med. 1998; 339: 387-395.
7. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999; 100: 1311-1315.
8. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997; 62: 187-193.
9. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004; 147: 331-338.
10. Ikram H, Chan W, Espiner EA, Nicholls MG. Haemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure. Clin Sci. 1980; 59: 443-449.
11. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987; 57: 17-22.
12. Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int. 1982; 22: 69-74.
13. Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996; 28: 376-382.
14. Lahav M, Regev A, Ra'anani P, Theodor E. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest. 1992; 102: 725-731.
15. Copeland JG, Campbell DW, Plachetka JR, Salmon NW, Larson DF. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg. 1983; 146: 796.
16. Lawson DH, Gray JMB, Henry DA, Tilstone WJ. Continuous infusion of furosemide in refractory edema. BMJ. 1978; 2: 476.
17. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010; 105: 1794-1797.
18. Aaser E, Gullestad L, Tølløfsrud S, et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest. 1997; 57: 361-367.
19. Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2005;( 3): CD003178.
20. Kramer WG, Smith WB, Ferguson J, et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol. 1996; 36: 265-270.
21. Licata G, Di Pasquale P, Parrinello G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003; 145: 459-466.
22. Schuller D, Lynch JP, Fine D. Protocol- guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997; 25: 1969-1975.
23. Cardiovascular Pharmacology Concepts. Diuretics. Available at:. Accessed July 22, 2010.
24. Mojtahedzadeh M, Tavakoli Ardakani M, Salehifar E, et al. The relationship between pharmacokinetics variables and pharmacodynamics profiles of bolus versus continuous infusion of furosemide in critically ill patients. J Infus Nurs. 2005; 13: 127-132.
25. Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010; 16: 188-193.
26. Ostermann M, Alvarez G, Sharpe MD, Martin CM. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract. 2007; 107: c70-c76.
27. Felker GM, Lee KL, Bull DA, et al; NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011; 364: 797-805.
28. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354: 1896-1900.
29. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1-12.
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634.
32. Pivac N, Rumboldt Z, Sardelić S, et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res. 1998; 18: 121-128.
33. Mojtahedzadeh M, Salehifar E, Vazin A, et al. Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients. Infus Nurs. 2004; 27: 255-261.
34. Brater DC. Diuretic resistance: mechanisms and therapeutic strategies. Cardiology. 1994; 84( suppl 2): 57-67.
35. Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol. 2003; 284: F11-F21.
36. Wilcox CS, Mitch WE, Kelly RA, et al. Response to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med. 1983; 102: 450-458.